MATHEMATICAL MODEL FOR COVID-19-PNEUMONIA DYNAMICS WITH VACCINATION AND ANTIVIRAL THERAPY

Authors

  • A. O. Oluwarotimi Department of Mathematical Sciences, Faculty of Basic and Applied Sciences, Osun State University, Osogbo, Nigeria Author
  • M. K. Kolawole Department of Mathematical Sciences, Faculty of Basic and Applied Sciences, Osun State University, Osogbo, Nigeria Author
  • A. O. Popoola Department of Mathematical Sciences, Faculty of Basic and Applied Sciences, Osun State University, Osogbo, Nigeria Author

DOI:

https://doi.org/10.60787/jnamp.vol73no.731

Keywords:

Rainfall, Markov chain, Stationary distribution, Mixing time, Total variation distance

Abstract

This study developed a seven-compartment COVID-19-pneumonia model This study develops a seven-compartment COVID-19-pneumonia model to assess the combined effects of pre-variant vaccination and antiviral therapy on transmission and pneumonia progression. The basic reproduction number was derived using the next-generation matrix, while equilibrium, stability, sensitivity, uncertainty, and Laplace-Adomian analyses characterized the dynamics using initial conditions from Osogbo, Nigeria. Vaccination and antiviral therapy jointly reduced infection and pneumonia burden; 60% vaccine protection with 40% antiviral uptake prevented more than 70% of projected pneumonia cases. Transmission, vaccine protection, and antiviral suppression were the dominant parameters. Coordinated deployment can therefore reduce severe disease and support COVID-19 control in resource-constrained settings.

         Views | Downloads: 36 / 10

Downloads

Download data is not yet available.

References

Zhou X, Chen H, Wang Y, Li Z, Zhao J, Liu Q, (2022). Clinical characteristics of mild COVID-19 cases. J Med Virol. 94(8):3502–3510. doi:10.1002/jmv.27952.

Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., Iotti, G., Latronico, N., Lorini, L., Merler, S., Natalini, G., Piatti, A., Ranieri, M. V., Scandroglio, A. M., Storti, E., … Pesenti, A. (2020). Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA, 323(16), 1574–1581. doi.org/10.1001/jama.2020.5394

Guan, W.J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., Du, B., Li, L.-J., Zeng, G., Yuen, K.-Y., Chen, R.-C., Tang, C.-L., Wang, T., Chen, P.-Y., Xiang, J., … Zhong, N.-S. (2020). Clinical characteristics of coronavirus disease 2019 in China. New England Journal of Medicine, 382(18), 1708–1720. doi.org/10.1056/NEJMoa2002032

Challen, R., Brooks-Pollock, E., Read, J. M., Dyson, L., Tsaneva-Atanasova, K., & Danon, L. (2021). Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study. BMI, 372. doi:10.1136/bmj.n579

Yoo, J. W., Kim, W. Y., Chung, C. R., Cho, Y. J., Lee, J., Jegal, Y., ... & Song, J. W. (2024). Early pulmonary fibrosis-like changes between delta and pre-delta periods in patients with severe COVID-19 pneumonia on mechanical ventilation. Scientific reports, 14(1), 26101. doi.org/10.1038/s41598-024-77405-7

Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W (2020). Correlation of Chest CT and RT-PCR Testing for Coronavirus Disease 2019 (COVID-19) in China: A Report of 1014 Cases. Radiology.296(2):E32–E40. doi:10.1148/radiol.2020200642.

Ito, N., Kitahara, Y., Miwata, K., Okimoto, M., & Takafuta, T. (2022). Comparison of COVID-19 pneumonia during the SARS-CoV-2 Omicron wave and the previous non-Omicron wave in a single facility. Respiratory Investigation, 60(6), 772–778. doi.org/10.1016/j.resinv.2022.08.001

Nyberg, T., Ferguson, N. M., Nash, S. G., Webster, H. H., Flaxman, S., Andrews, N., Hinsley, W., Bhatt, S., Cucunubá, Z. M., & Lessler, J. (2022). Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants in England: A cohort study. The Lancet, 399(10332), 1303–1312. doi.org/10.1016/S0140-6736(22)00462-7

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson J.J (2020). COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet;395(10229):1033–1034. doi:10.1016/S0140-6736(20)30628-0.

Wiersinga, W. J., Rhodes, A., Cheng, A. C., Peacock, S. J., & Prescott, H. C. (2020). Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): A review. JAMA, 324(8), 782–793. doi.org/10.1001/jama.2020.12839

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., Guan, L., Wei, Y., Li, H., Wu, X., Xu, J., Tu, S., Zhang, Y., Chen, H., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. The Lancet, 395(10229), 1054–1062. doi.org/10.1016/S0140-6736(20)30566-3

Torres A, Cilloniz C, Niederman MS, Menéndez R, Chalmers JD, Wunderink RG (2021), van der Poll T. Pneumonia. Nat Rev Dis Primers. Apr 8;7(1):25. doi: 10.1038/s41572-021-00259-0. PMID: 33833230

Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., Lopez de Castilla, D., Finberg, R. W., Dierberg, K., Tapson, V., Ssenator, L., McGettigan, T. H., Bhimraj, A., Coli, K. M., & Lane, H. C. (2020). Remdesivir for the treatment of COVID-19 final report. New England Journal of Medicine, 383(19), 1813–1826. doi.org/10.1056/NEJMoa2007764

Ko, Y., Lee, J., Kim, Y., Kwon, D., & Jung, E. (2021). COVID19 vaccine priority strategy using a heterogeneous transmission model based on maximum likelihood estimation in the Republic of Korea. International Journal of Environmental Research and Public Health,18(12), Article 6469. doi.org/10.3390/ijerph18126469

Liossi, S., Tsiambas, E., Maipas, S., Papageorgiou, E., Lazaris, A., & Kavantzas, N. (2023). Mathematical modeling for Delta and Omicron variant of SARS-CoV-2 transmission dynamics in Greece. Infectious Disease Modelling, 8(3), 794–805.

Oh, J., Apio, C., & Park, T. (2022). Mathematical modelling of the impact of Omicron variant on the COVID-19 situation in South Korea. Genomics & Informatics, 20(2), Article e22. doi.org/10.5808/gi.22025

Jeeva, N., Dharmalingam, K. M., Fadugba, S. E., Kekana, M. C., & Adeniji, A. A. (2024). Implementationof Laplace Adomian decomposition and differential transform methods for Sars-Cov-2 model. Journal of applied mathematics & informatics, 42(4), 945-968..doi.org/10.14317/jami.2024.945

Van den Driessche, P., & Watmough, J. (2002). Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission. Mathematical Biosciences, 180(1–2), 29–48. doi.org/10.1016/S0025-5564(02)00108-6

Bernal, L. J., Andrews, N., Gower, C., Robertson, C., Stowe, J., Tessier, E., Simmons, R., Cottrell, S., Roberts, R., O'Doherty, M., Brown, K., Cameron, C., Stockton, D., McMenamin, J., & Ramsay, M. (2021). Effectiveness of COVID-19 vaccines against the B.1.617.2 (Delta) variant. New England Journal of Medicine, 385(7), 585–594. doi.org/10.1056/NEJMoa2108891

National Bureau of Statistics (NBS). Population and demographic data reports. Abuja (Nigeria): NBS; 2022. [last visited August 15, 2025]. Available from: https://www.nigerianstat.gov.ng/elibrary/read/1241422.

Cai, M., Em Karniadakis, G., & Li, C. (2022). Fractional SEIR model and data-driven predictions of COVID-19 dynamics of Omicron variant. Chaos: An Interdisciplinary Journal of Nonlinear Science, 32(7). doi.org/10.1063/5.0099450

Zhang, H., Ge, C., Fisher, D., Nguyen, H., Musabaev, E., Pronyuk, K., Zhao, L., & Xu, L. (2025). Antiviral treatment for viral pneumonia: Current drugs and natural compounds. Virology Journal, 22(1), 1–10. doi.org/10.1186/s12985-025-02666-1

World Health Organization (WHO). Clinical management of COVID-19: Living guidance. Geneva (Switzerland): WHO; (2022). [last visited August 15, 2025]. Available from: https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2022.

Yatera K, Yamasaki K, (2025). Management of the diagnosis and treatment of pneumonia in an aging society. Internal Medicine.64(4):503–517

Zhao L, Wang T, Li J, Xu F, Chen Y, Huang X, et al.(2025) Clinical effectiveness of oral antiviral treatment for non-severe COVID-19 pneumonia. Pneumonia.17:168. doi:10.1186/s41479-025-00168-w.

Nigeria Centre for Disease Control (NCDC). (2025, April 5). Weekly epidemiological report, March 2025 (Vol. 15, No. 12). https://ncdc.gov.ng/reports/weekly

A. I. Alaje and M. O. Olayiwola, “A fractional-order mathematical model for examining the spatiotemporal spread of COVID-19 in the presence of vaccine distribution,” Healthcare Analytics, vol. 4, Article 100230, 2023.

M. O. Olayiwola, A. I. Alaje, A. Y. Olarewaju, and K. A. Adedokun, “A Caputo fractional order epidemic model for evaluating the effectiveness of high-risk quarantine and vaccination strategies on the spread of COVID-19,” Healthcare Analytics, vol. 3, Article 100179, 2023.

T. A. Ayoola, A. O. Popoola, M. O. Olayiwola, and A. I. Alaje, “Mathematical modeling of chickenpox

transmission using the Laplace–Adomian decomposition method,” Results in Control and Optimization, vol. 15, Article 100436, 2024.

Downloads

Published

2026-08-18

Issue

Section

Articles

How to Cite

MATHEMATICAL MODEL FOR COVID-19-PNEUMONIA DYNAMICS WITH VACCINATION AND ANTIVIRAL THERAPY. (2026). The Journals of the Nigerian Association of Mathematical Physics, 73, 99-122. https://doi.org/10.60787/jnamp.vol73no.731

Share

Similar Articles

51-60 of 78

You may also start an advanced similarity search for this article.